Literature DB >> 12967165

Globalization and the transfer of hazardous industry: asbestos in Mexico, 1979-2000.

Guadalupe Aguilar-Madrid1, Cuauhtémoc A Juárez-Pérez, Steven Markowitz, Mauricio Hernández-Avila, Francisco Raúl Sanchez Roman, Juan Humberto Vázquez Grameix.   

Abstract

This study quantified asbestos use in Mexico in the past decade and evaluated available data on mortality due to malignant mesothelioma in Mexico between 1979 and 2000. Mortality data were analyzed from secondary databases of the Mexican Social Security System and the Ministry of Health. Data on the import and export of asbestos in Mexico were obtained from the Ministry of Trade and Industrial Development of Mexico. Deaths due to pleural mesothelioma significantly increased in this period. Although the import of asbestos declined, the number of Mexican products that contain asbestos tripled. Export of Mexican asbestos-containing products to Central America grew rapidly in the last ten years of the study. Mexico continues the appreciable use of asbestos and has experienced a significant increase in the occurrence of the sentinel asbestos-related disease, malignant mesothelioma. Given the many limitations to the control of hazardous work exposures in Mexico, a ban on asbestos is advocated as the most feasible means of limiting an epidemic of asbestos-related disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967165     DOI: 10.1179/oeh.2003.9.3.272

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  6 in total

1.  Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma.

Authors:  Carmina Jiménez-Ramírez; Swaantje Casjens; Cuauhtémoc Arturo Juárez-Pérez; Irina Raiko; Luz M Del Razo; Dirk Taeger; Emma S Calderón-Aranda; Hans-Peter Rihs; Leonor Concepción Acosta-Saavedra; Daniel Gilbert Weber; Alejandro Cabello-López; Beate Pesch; María Dolores Ochoa-Vázquez; Katarzyna Burek; Luis Torre-Bouscoulet; José Rogelio Pérez-Padilla; Erik Marco García-Bazan; Thomas Brüning; Georg Johnen; Guadalupe Aguilar-Madrid
Journal:  Lung       Date:  2019-07-02       Impact factor: 2.584

2.  Investigating cancer risks related to asbestos and other occupational carcinogens.

Authors:  Jack Siemiatycki
Journal:  Occup Environ Med       Date:  2007-08       Impact factor: 4.402

3.  Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.

Authors:  Jeronimo Rafael Rodríguez-Cid; Orlando García-Acevedo; Javier Benjamin-Contreras; Diana Bonilla-Molina; Rodrigo Rafael Flores-Mariñelarena; Luis Martínez-Barrera; Jorge Arturo Alatorre-Alexander; Carla Paola Sanchez-Ríos; Maria Del Rosario Flores-Soto; Patricio Javier Santillan-Doherty; Erika Sagrario Peña-Mirabal
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 4.  Prevention of Asbestos Exposure in Latin America within a Global Public Health Perspective.

Authors:  Eduardo Algranti; Juan Pablo Ramos-Bonilla; Benedetto Terracini; Vilma S Santana; Pietro Comba; Roberto Pasetto; Agata Mazzeo; Fulvio Cavariani; Andrés Trotta; Daniela Marsili
Journal:  Ann Glob Health       Date:  2019-03-29       Impact factor: 2.462

5.  Assessment of miR-103a-3p in leukocytes-No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis.

Authors:  Carmina Jiménez-Ramírez; Daniel Gilbert Weber; Guadalupe Aguilar-Madrid; Alexander Brik; Cuauhtémoc Arturo Juárez-Pérez; Swaantje Casjens; Irina Raiko; Thomas Brüning; Georg Johnen; Alejandro Cabello-López
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

6.  Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.

Authors:  Guadalupe Aguilar-Madrid; Beate Pesch; Emma S Calderón-Aranda; Katarzyna Burek; Carmina Jiménez-Ramírez; Cuauhtémoc Arturo Juárez-Pérez; María Dolores Ochoa-Vázquez; Luis Torre-Bouscoulet; Leonor Concepción Acosta-Saavedra; Isabel Sada-Ovalle; Jorge García-Figueroa; Isabel Alvarado-Cabrero; Patricia Castillo-González; Alejandra Renata Báez-Saldaña; José Rogelio Pérez-Padilla; Juvencio Osnaya-Juárez; Rosa María Rivera-Rosales; Eric Marco García-Bazán; Yolanda Lizbeth Bautista-Aragón; Elimelec Lazcano-Hernandez; Daniel Alejandro Munguía-Canales; Luis Marcelo Argote-Greene; Dirk Taeger; Daniel Gilbert Weber; Swaantje Casjens; Irina Raiko; Thomas Brüning; Georg Johnen
Journal:  Int J Med Sci       Date:  2018-06-04       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.